238 related articles for article (PubMed ID: 29497929)
1. Prognostic Value of Cyclin D1 and CD44 Expression in Gastric Adenocarcinoma.
Ibrahim HM; AbdElbary AM; Mohamed SY; Elwan A; Abdelhamid MI; Ibrahim A
J Gastrointest Cancer; 2019 Sep; 50(3):370-379. PubMed ID: 29497929
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer.
Kodama H; Murata S; Ishida M; Yamamoto H; Yamaguchi T; Kaida S; Miyake T; Takebayashi K; Kushima R; Tani M
Br J Cancer; 2017 Jan; 116(2):186-194. PubMed ID: 27931044
[TBL] [Abstract][Full Text] [Related]
3. Association of Two CD44 Polymorphisms with Clinical Outcomes of Gastric Cancer Patients.
Bitaraf SM; Mahmoudian RA; Abbaszadegan M; Mohseni Meybodi A; Taghehchian N; Mansouri A; Forghanifard MM; Memar B; Gholamin M
Asian Pac J Cancer Prev; 2018 May; 19(5):1313-1318. PubMed ID: 29802692
[TBL] [Abstract][Full Text] [Related]
4. The Expression of p53, CD44, Ki-67, and HER-2/neu Markers in Gastric Cancer and Its Association with Histopathological Indicators: A Retrospective Study.
Ahadi M; Moradi A; Musavinejad L; Movafagh A; Moradi A
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1607-1614. PubMed ID: 32592354
[TBL] [Abstract][Full Text] [Related]
5. G1/S-specific cyclin-D1 might be a prognostic biomarker for patients with laryngeal squamous cell carcinoma.
Zhang YY; Xu ZN; Wang JX; Wei DM; Pan XL
Asian Pac J Cancer Prev; 2012; 13(5):2133-7. PubMed ID: 22901182
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic Value of CD44 Expression in Epithelial-Mesenchymal Transition: Preliminary Data from Patients with Gastric and Esophageal Cancer.
Schizas D; Moris D; Kanavidis P; Michalinos A; Sioulas A; Pavlakis K; Machairas A; Liakakos T
In Vivo; 2016 11-12; 30(6):939-944. PubMed ID: 27815484
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of IC53d promotes the proliferation of gastric cancer cells by activating the AKT/GSK3β/cyclin D1 signaling pathway.
Lin JX; Xie XS; Weng XF; Qiu SL; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Li P; Huang CM; Zheng CH
Oncol Rep; 2019 May; 41(5):2739-2752. PubMed ID: 30864700
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD44 variant 6 and lymphatic invasion: importance to lymph node metastasis in gastric cancer.
Kurozumi K; Nishida T; Nakao K; Nakahara M; Tsujimoto M
World J Surg; 1998 Aug; 22(8):853-7; discussion 857-8. PubMed ID: 9673558
[TBL] [Abstract][Full Text] [Related]
9. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes.
Tenderenda M
J Exp Clin Cancer Res; 2005 Sep; 24(3):405-14. PubMed ID: 16270527
[TBL] [Abstract][Full Text] [Related]
10. Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.
Yuan C; Zhu X; Han Y; Song C; Liu C; Lu S; Zhang M; Yu F; Peng Z; Zhou C
J Exp Clin Cancer Res; 2016 Jan; 35():15. PubMed ID: 26791264
[TBL] [Abstract][Full Text] [Related]
11. CD44/CD24 expression in recurrent gastric cancer: a retrospective analysis.
Yong CS; Ou Yang CM; Chou YH; Liao CS; Lee CW; Lee CC
BMC Gastroenterol; 2012 Jul; 12():95. PubMed ID: 22839505
[TBL] [Abstract][Full Text] [Related]
12. [Expression tumor stem cell surface marker CD44 in gastric cancer and its significance].
Xie JW; Huang CM; Zheng CH; Li P; Wang JB; Lin JX; Lu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Nov; 16(11):1107-12. PubMed ID: 24277411
[TBL] [Abstract][Full Text] [Related]
13. LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma.
Li H; Piao L; Xu D; Xuan Y
Exp Mol Pathol; 2020 Feb; 112():104333. PubMed ID: 31705880
[TBL] [Abstract][Full Text] [Related]
14. Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma.
Bhatavdekar JM; Patel DD; Chikhlikar PR; Shah NG; Vora HH; Ghosh N; Trivedi TI
Dis Colon Rectum; 2001 Apr; 44(4):523-33. PubMed ID: 11330579
[TBL] [Abstract][Full Text] [Related]
15. Selected proliferation markers correlated with dynamics of growth in colorectal cancer.
Luo WX; Chen Y; Li YT; Tang J; Ding J; Du Y; Wu Q; Liu JY
Eur J Cancer Prev; 2019 May; 28(3):181-187. PubMed ID: 29688906
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of galectin-3 and cyclin D1 expression in undifferentiated nasopharyngeal carcinoma.
Acikalin MF; Etiz D; Gurbuz MK; Ozudogru E; Canaz F; Colak E
Med Oncol; 2012 Jun; 29(2):742-9. PubMed ID: 21553103
[TBL] [Abstract][Full Text] [Related]
17. Predictive Value of CD44 in Muscle-Invasive Bladder Cancer and Its Relationship with IL-6 Signaling.
Wu CT; Lin WY; Chen WC; Chen MF
Ann Surg Oncol; 2018 Nov; 25(12):3518-3526. PubMed ID: 30128900
[TBL] [Abstract][Full Text] [Related]
18. [Expression and significance of cell cycle regulators in gastric carcinoma].
Wu JF; Shao JC; Wang DB; Qin R; Zhang H
Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028
[TBL] [Abstract][Full Text] [Related]
19. [Expressions of CD133 and CD44 in gastric adenocarcinoma and their relationship with E-cadherin expression].
Lu G; Wu X; Zhou L; Yu L; Wu S
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1632-7. PubMed ID: 24273267
[TBL] [Abstract][Full Text] [Related]
20. Abnormal expression of pRb, p16, and cyclin D1 in gastric adenocarcinoma and its lymph node metastases: relationship with pathological features and survival.
Feakins RM; Nickols CD; Bidd H; Walton SJ
Hum Pathol; 2003 Dec; 34(12):1276-82. PubMed ID: 14691913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
